✦ LIBER ✦

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

✍ Scribed by Michael Böhm; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi

Book ID: 117307170
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 328 KB
Volume: 376
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)61259-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ivabradine and outcomes in chronic heart

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

✍ Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane D 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 404 KB

Ivabradine and outcomes in chronic heart

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

✍ Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane D 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 404 KB

## Background: Chronic heart failure is associated with high mortality and morbidity. raised resting heart rate is a risk factor for adverse outcomes. we aimed to assess the effect of heart-rate reduction by the selective sinus-node inhibitor ivabradine on outcomes in heart failure. ## Methods: P

Results of a non-specific immunomodulati

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial

✍ Guillermo Torre-Amione; Stefan D Anker; Robert C Bourge; Wilson S Colucci; Barry 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 643 KB

Adherence to candesartan and placebo and

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

✍ Bradi B Granger; Karl Swedberg; Inger Ekman; Christopher B Granger; Bertil Olofs 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 124 KB

Effect of rosuvastatin in patients with

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

✍ GISSI-HF investigators 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 164 KB

Heart rate as a prognostic risk factor i

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

✍ Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Michele Robertson; Roberto Fe 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 152 KB